VERRICA PHARMACEUTICALS INC(NASDAQ:VRCA) stock News

VRCA Latest News, Press Relases and Analysis

All

Press Releases

2 days ago - By: Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Receives Positive Feedback from the European Medicines Agency (EMA) Supporting a Clear Regulatory Path Forward to File for Approval of YCANTH® in the European Union

2 days ago - By: Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Receives Positive Feedback from the European Medicines Agency (EMA) Supporting a Clear Regulatory Path Forward to File for Approval of YCANTH® in the European Union

15 days ago - By: Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals to Present New Data on VP-315 from its Phase 2 Trial in Basal Cell Carcinoma (BCC) at the 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting

2 months ago - By: Benzinga

What to Expect from Verrica Pharmaceuticals's Earnings

5 months ago - By: Benzinga

Earnings Outlook For Verrica Pharmaceuticals

15 days ago - By: Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals to Present New Data on VP-315 from its Phase 2 Trial in Basal Cell Carcinoma (BCC) at the 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting

a month ago - By: Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Announces That Development Partner, Torii Pharmaceutical, Receives Approval for YCANTH® (TO-208) in Japan for the Treatment of Molluscum Contagiosum

a month ago - By: Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Announces That Development Partner, Torii Pharmaceutical, Receives Approval for YCANTH® (TO-208) in Japan for the Treatment of Molluscum Contagiosum

2 months ago - By: Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

2 months ago - By: Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

2 months ago - By: The Motley Fool

Verrica Posts Profit in Fiscal Q2

2 months ago - By: Zacks Investment Research - Mentions: IGC

Verrica Pharmaceuticals Inc. (VRCA) Q2 Earnings and Revenues Beat Estimates

2 months ago - By: Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Reports Second Quarter 2025 Financial Results

2 months ago - By: Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Reports Second Quarter 2025 Financial Results

3 months ago - By: Zacks Investment Research - Mentions: SLNO

Soleno Therapeutics, Inc. (SLNO) Reports Q2 Loss, Tops Revenue Estimates

3 months ago - By: Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals to Report Second Quarter 2025 Financial Results and Provide a Corporate Update on August 12, 2025

3 months ago - By: Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals to Report Second Quarter 2025 Financial Results and Provide a Corporate Update on August 12, 2025

4 months ago - By: Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Reports Strong Growth in YCANTH® Dispensed Applicator Units in 2Q 2025

4 months ago - By: Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Announces Amendment to Collaboration and License Agreement with Torii Pharmaceutical to Launch Global Pivotal Phase 3 Clinical Trial to Study YCANTH® for the Treatment of Common Warts

4 months ago - By: Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Announces Amendment to Collaboration and License Agreement with Torii Pharmaceutical to Launch Global Pivotal Phase 3 Clinical Trial to Study YCANTH® for the Treatment of Common Warts

5 months ago - By: Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in New York

5 months ago - By: Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in New York

5 months ago - By: Zacks Investment Research - Mentions: IPSC

Verrica Pharmaceuticals Inc. (VRCA) Reports Q1 Loss, Tops Revenue Estimates

5 months ago - By: Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Reports Quarterly 2025 Financial Results

5 months ago - By: Verrica Pharmaceuticals Inc. - Mentions: TVTX

Verrica Pharmaceuticals Reports Quarterly 2025 Financial Results

5 months ago - By: Zacks Investment Research - Mentions: ASRT

Assertio (ASRT) Reports Q1 Loss, Misses Revenue Estimates

6 months ago - By: Zacks Investment Research - Mentions: FDMT

4D Molecular Therapeutics, Inc. (FDMT) Reports Q1 Loss, Lags Revenue Estimates

6 months ago - By: Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 13, 2025

6 months ago - By: Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 13, 2025

6 months ago - By: Zacks Investment Research - Mentions: AMRX

Amneal Pharmaceuticals (AMRX) Q1 Earnings Beat Estimates

6 months ago - By: Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals to Participate in the Citizens Life Sciences Conference in New York

6 months ago - By: Verrica Pharmaceuticals Inc.

VERRICA PHARMACEUTICALS INC (VRCA) Stock News

VRCA Latest News, Press Relases and Analysis